Home  /  Resource Library  /  G-CSF Appears Safe in CAR-T Treated Patients With Refractory/Relapsed B-Cell Lymphoma

G-CSF Appears Safe in CAR-T Treated Patients With Refractory/Relapsed B-Cell Lymphoma

Results of a study investigating granulocyte colony-stimulating factor therapy for treating neutropenia following CAR T therapy.